Reports for BAUSCH HEALTH, CANADA INC.

Company Name

BAUSCH HEALTH, CANADA INC.

Totals

Shortage reports

306
Actual shortage: 12 (4%)
Anticipated shortage: 6 (2%)
Avoided shortage: 25 (8%)
Resolved: 263 (86%)

Discontinuation Reports

1
To be discontinued: 0 (0%)
Discontinued: 1 (100%)
Reversed: 0 (0%)

Late reports

90 (29%)

Overdue reports

1 (6%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
LODALIS 625MG TABLET Resolved 2018-11-09 2018-12-14 66589
LODALIS 625MG TABLET Resolved 2019-03-05 2019-04-03 77834
LODALIS 625MG TABLET Resolved 2020-04-01 2020-04-09 110373
LODALIS 625MG TABLET Resolved 2020-08-13 2020-09-10 122119
LODALIS 625MG TABLET Resolved 2023-01-11 2023-03-04 180700
EDARBI 40MG TABLET Resolved 2019-06-21 2019-06-27 87192
EDARBI 40MG TABLET Resolved 2019-09-10 2019-11-19 93519
EDARBI 40MG TABLET Resolved 2020-01-10 2020-02-28 103031
EDARBI 40MG TABLET Resolved 2020-04-01 2020-05-13 110370
EDARBI 80MG TABLET Resolved 2019-09-10 2019-11-19 93523
SUBLINOX 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-03-02 2018-06-30 41543
SUBLINOX 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-06-12 2019-07-05 86505
SUBLINOX 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-10-10 2019-10-17 96014
SUBLINOX 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-10-05 2021-12-09 146697
EDARBYCLOR 12.5MG 40MG TABLET Resolved 2018-08-24 2019-01-23 58987
EDARBYCLOR 12.5MG 40MG TABLET Resolved 2019-07-05 2019-08-14 88781
EDARBYCLOR 12.5MG 40MG TABLET Resolved 2019-11-13 2020-01-23 98634
EDARBYCLOR 12.5MG 40MG TABLET Resolved 2020-04-01 2020-04-24 110367
EDARBYCLOR 25MG 40MG TABLET Resolved 2018-08-24 2018-11-09 58990
EDARBYCLOR 25MG 40MG TABLET Resolved 2019-05-08 2019-11-19 83468

Showing 281 to 300 of 306

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
THEOLAIR 80MG SOLUTION Discontinued 2021-04-26 2021-04-27 138081

Showing 1 to 1 of 1